Search form

Joseph Lazzarotti Discusses Implications of New FDA Approved Digital Pill

Joseph Lazzarotti discusses the first FDA approved drug with an embedded electronic sensor and concerns surrounding its security of patient data in "Amid Privacy Concerns, Medication Ushers In Brave New World of ‘Digital Medicine,’" published by the Health Care Compliance Association.

 

 

Mentioned

Practices

People

See AllRelated News

February 20, 2018
Business News Daily

Joseph Lazzarotti Comments on Employee Monitoring Ethics

February 20, 2018

Joseph Lazzarotti comments on employers finding the balance between business interests and privacy rights with employee monitoring in "The Laws and Ethics of Employee Monitoring," Business News Daily. Subscription may be required to view article Read More

January 8, 2018
Jackson Lewis

Joseph Lazzarotti Discusses HR Professionals Playing an Increased Role in Cybersecurity

January 8, 2018

Joseph Lazzarotti discusses HR professionals becoming more involved in organizations' cybersecurity planning and implementation, such as workplace GPS tracking and biometric data collection in "How Will Workplace GPS Tracking and Biometric Data Collection Trends Affect HR?" published by SHRM. Subscription may be required to view... Read More

November 3, 2017
Law 360

Lisa Marrello Discusses Anoush Koroghlian-Scott Joining Jackson Lewis

November 3, 2017

Lisa Marrello discusses Anoush Koroghlian-Scott recently joining Jackson Lewis, focusing her practice on health care and data security in "Health Hires: Jackson Lewis, EBG, Spencer Fane, AMRI," published by Law360. Subscription may be required to view article Read More